Skip to main content
Caplight Logo









BranchLab

BranchLab

Private
Boulder, ColoradoHealthcare & Life Scienceshttps://branchlab.com/

Last Round

Series A

May 13, 2026

Total Funding Raised

$35M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

BranchLab is a healthcare AI company that provides a platform for predicting health outcomes and improving decision-making for regulated organizations.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Marketing, Medical AI, Digital Advertising

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Services & Consulting

AI Layer

Application

Keywords

pharma commercializationAI platformpharma marketinghealth outcome predictionpredictive analyticsPharmaTechpharma adtechprivacy-first AIpatient targetingHCP targetingaudience segmentationHIPAA compliantcommercial intelligencede-identified dataB2B SaaStransformer-based AIprotected health informationPHIthird-party cookie deprecation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BranchLab Comparables

Compare BranchLab with similar companies based on industry and business-model similarity.

BranchLab comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ODAIA
81%
Veeva Systems
79%
Real Chemistry
76%

BranchLab Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 13, 2026
SeedJun 6, 2024

Key People

Founding team and executive leadership

Michael Parkes

Co-Founder, President & CRO

Founding Team

BranchLab Investors

Notable investors and investment history

BranchLab investors
InvestorRounds
McKesson VenturesSeries A
FCA Venture PartnersSeries A
Newark Venture PartnersSeed
Sanofi VenturesSeries A
Aperiam VenturesSeed
AIX VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 30, 2026

    Grew 18% QoQ, from 40 to 47 employees.

  • Jul 27, 2026

    Open roles increased to 45, representing 100% of headcount.

BranchLab Filings

Explore SEC and related filing metadata, where available.

BranchLab filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BranchLab's valuation, stock price, and market status.

Is BranchLab a public or private company?

BranchLab is a private company.

What is the current stock price of BranchLab?

BranchLab is a private company with no public stock price. No recent secondary market data is available.

How much is BranchLab worth (valuation)?

Valuation information for BranchLab is not publicly available.

Can I buy BranchLab stock?

BranchLab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BranchLab's last funding round?

BranchLab's most recent funding round was Series A on May 13, 2026.

Who are the main investors in BranchLab?

Key investors in BranchLab include McKesson Ventures.

Will BranchLab IPO soon?

No public IPO plans have been announced for BranchLab.

How can I track BranchLab secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BranchLab's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoulder, Colorado
Employee Range41
Year Founded2024
Last FundingMay 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?